Skip to main content
. Author manuscript; available in PMC: 2024 Feb 6.
Published in final edited form as: Brain Behav Immun. 2021 Nov 19;100:121–133. doi: 10.1016/j.bbi.2021.11.009

Table 3A:

Adjusted odds ratios comparing neonatal cytokine and chemokine concentrations in ASD, DD, and TD in one model, N=398a

Cytokine or Chemokine ASD vs. TD ASD vs. DD DD vs. TD
OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value
CTACK 0.40 (0.21, 0.77) 0.01 0.49 (0.21, 1.14) 0.10 0.82 (0.35, 1.94) 0.65
MPIF-1 0.95 (0.62, 1.45) 0.81 2.38 (1.42, 3.98) 0.001 0.40 (0.24, 0.68) 0.001
MIF 0.59 (0.24, 1.48) 0.26 1.21 (0.65, 2.25) 0.56 0.49 (0.18, 1.34) 0.17
a

Multinomial logistic regression model was adjusted for maternal education, gestational age, child’s age at blood spot collection, and years from blood spot collection to elution; cytokines/chemokines were ln-transformed and normalized for total protein (pg/mg total protein); OR represents the fold change in the odds of having one diagnosis relative to another diagnosis or no diagnosis for every 1-unit increase in the ln-transformed cytokine/chemokine (or for every e-fold increase in cytokine/chemokine levels); 398 participants comprised the following groups: 171 ASD, 69 DD and 158 TD; OR = adjusted odds ratio, CI = confidence interval